We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+8.06%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$66.5B
AUM Growth
+$8.68B
(+15%)
Cap. Flow
+$4.4B
Cap. Flow
% of AUM
6.62%
Top 10 Holdings %
Top 10 Hldgs %
43.86%
Holding
2,667
New
353
Increased
1,277
Reduced
719
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$322M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$296M |
| 3 |
Avantis US Equity ETF
AVUS
|
+$283M |
| 4 |
Schwab US Large- Cap ETF
SCHX
|
+$280M |
| 5 |
Vanguard Total Bond Market
BND
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$76.1M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$59.3M |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$20.7M |
| 4 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
+$19.6M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$18.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.02% |
| 2 | Financials | 2.97% |
| 3 | Healthcare | 1.72% |
| 4 | Consumer Discretionary | 1.4% |
| 5 | Consumer Staples | 1.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Vertex Pharmaceuticals
VRTX
$122B
| $18.9M | 0.03% |
65,460
+56,673
| +645% | +$17.3M |
|
227
Vanguard Global ex-US Real Estate ETF
VNQI
$3.47B
| $18.6M | 0.03% |
449,860
-17,249
| -4% | -$688K |
|
228
Crown Castle
CCI
$33.2B
| $18.4M | 0.03% |
135,852
-7,338
| -5% | -$992K |
|
229
Enterprise Products Partners
EPD
$83.8B
| $18.3M | 0.03% |
757,244
+68,900
| +10% | +$1.7M |
|
230
Northrop Grumman
NOC
$76.5B
| $17.9M | 0.03% |
32,742
+1,585
| +5% | +$827K |
|
231
3M
MMM
$88.6B
| $17.5M | 0.03% |
174,038
+2,820
| +2% | +$288K |
|
232
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.2B
| $17.4M | 0.03% |
488,940
+147,550
| +43% | +$5.59M |
|
233
Amphenol
APH
$191B
| $17.3M | 0.03% |
455,578
-22,014
| -5% | -$833K |
|
234
iShares MSCI USA Min Vol Factor ETF
USMV
$23.3B
| $17.2M | 0.03% |
238,249
+7,775
| +3% | +$553K |
|
235
Norfolk Southern
NSC
$79.2B
| $16.9M | 0.03% |
68,593
+2,281
| +3% | +$540K |
|
236
Colgate-Palmolive
CL
$72.4B
| $16.9M | 0.03% |
214,216
-276
| -0.1% | -$20.7K |
|
237
CVS Health
CVS
$137B
| $16.8M | 0.03% |
180,102
+9,816
| +6% | +$947K |
|
238
American Express
AXP
$221B
| $16.8M | 0.03% |
113,481
+3,935
| +4% | +$583K |
|
239
Marathon Petroleum
MPC
$90.7B
| $16.7M | 0.03% |
143,678
+27,508
| +24% | +$3.14M |
|
240
TJX Companies
TJX
$171B
| $16.4M | 0.02% |
205,446
+20,336
| +11% | +$1.5M |
|
241
iShares S&P 500 Value ETF
IVE
$49B
| $16.1M | 0.02% |
110,900
+9,064
| +9% | +$1.29M |
|
242
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.6B
| $16.1M | 0.02% |
338,743
+40,031
| +13% | +$1.91M |
|
|
FRC
243
DELISTED
First Republic Bank
FRC
| $15.9M | 0.02% |
130,254
+17,437
| +15% | +$2.13M |
|
244
Intuit
INTU
$80.2B
| $15.7M | 0.02% |
40,219
+2,577
| +7% | +$1.02M |
|
245
Vanguard Mid-Cap Growth ETF
VOT
$19.2B
| $15.4M | 0.02% |
85,568
+12,500
| +17% | +$2.26M |
|
246
Vanguard Health Care ETF
VHT
$18.2B
| $15.3M | 0.02% |
61,539
-1,535
| -2% | -$372K |
|
247
Emerson Electric
EMR
$83.2B
| $15.2M | 0.02% |
158,440
-774
| -0.5% | -$69.6K |
|
248
Janus Henderson Short Duration Income ETF
VNLA
$3.33B
| $15.1M | 0.02% |
318,621
+113,258
| +55% | +$5.48M |
|
249
Stryker
SYK
$126B
| $15M | 0.02% |
61,543
+8,870
| +17% | +$2.01M |
|
250
Dimensional US Core Equity Market ETF
DFAU
$12.3B
| $14.9M | 0.02% |
552,984
+544,435
| +6,368% | +$14.8M |
|
Similar funds
Creative Planning's Q4 2022 Portfolio in Review
As of Q4 2022, Creative Planning held 2,667 positions worth $66.5B, up 15% from $57.8B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Creative Planning deployed $4.4B of net new capital in Q4 2022, opening 353 new positions and adding to 1,277 existing holdings. Its largest new stake was Avantis US Equity ETF: 4,140,930 shares worth $282M.
By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 4.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 ETF, an estimated $76.1M trimmed.
- Creative Planning's largest Q4 2022 buy was Avantis US Equity ETF: 4,140,930 shares worth $282M.
- Creative Planning added most to iShares Core MSCI International Developed Markets ETF in Q4 2022, an estimated $322M increase.
- Creative Planning's biggest Q4 2022 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $76.1M.
- Creative Planning fully exited Veradigm Inc. Common Stock in Q4 2022, selling an estimated $19.6M.
- Creative Planning's ten largest holdings make up 44% of its $66.5B portfolio in Q4 2022.
- Creative Planning opened 353 new positions and closed 180 in Q4 2022.
- Creative Planning's portfolio value rose 15% quarter-over-quarter to $66.5B.
Based on Creative Planning's 13F filing for Q4 2022, filed 10 Feb 2023.